1Sahgstein SL. Pulmonary malignant lymphomas and seudolymbhomas:classification, therapy and prognosis. Cancer, 1963, 16: 928.
2Herbert A,Wright DH, lsaacson PG,et al. Primary malignant lymphoma of the lung :histopathologic and immunologic evaluation of nine cases.Hum Patol, 1984,15:415.
5Graham BB, Mathisen DJ, Mark EJ, et al. Primary Pulmonary Lymphoma. Ann Thorac Surg, 2005,80(4) : 1248.
6Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of ext ranodal lymphomas. Cancer, 1972,29 ( 1 ) : 252-260.
7Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst,1994,86(22):1711-1716.
8Koss MN, Hochholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol,1983,14(12) :1024- 1038.
9Cordier JF, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest, 1993,103 ( 1 ) : 201-208.
10Freudenberg LS,Antoch G. FDG PET-CT in restaging of patients with lymphoma. Eur J Nucl Med Mol Imaging,2004,31(3):325-329.
